Surgery Partners Inc (SGRY) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Surgery Partners Inc stock (SGRY) is currently trading at $12.05. Surgery Partners Inc PS ratio (Price-to-Sales) is 0.46. Analyst consensus price target for SGRY is $19.34. WallStSmart rates SGRY as Underperform.
- SGRY PE ratio analysis and historical PE chart
- SGRY PS ratio (Price-to-Sales) history and trend
- SGRY intrinsic value — DCF, Graham Number, EPV models
- SGRY stock price prediction 2025 2026 2027 2028 2029 2030
- SGRY fair value vs current price
- SGRY insider transactions and insider buying
- Is SGRY undervalued or overvalued?
- Surgery Partners Inc financial analysis — revenue, earnings, cash flow
- SGRY Piotroski F-Score and Altman Z-Score
- SGRY analyst price target and Smart Rating
Surgery Partners Inc
📊 No data available
Try selecting a different time range
Smart Analysis
Surgery Partners Inc (SGRY) · 9 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales, price/book, institutional own.. Concerns around return on equity and revenue growth. Fundamentals are solid but monitor weak areas for improvement.
Surgery Partners Inc (SGRY) Key Strengths (3)
Paying less than $1 for every $1 of annual revenue
Trading below book value, meaning the market prices it less than net assets
122.17% of shares held by major funds and institutions
Supporting Valuation Data
Surgery Partners Inc (SGRY) Areas to Watch (6)
Company is losing money with a negative profit margin
Very low returns on shareholder equity
Revenue growing slowly at 2.40% annually
Small-cap company with higher risk but more growth potential
Growth is fairly priced, not cheap, not expensive
Decent operational efficiency, solid but not exceptional
Supporting Valuation Data
Surgery Partners Inc (SGRY) Detailed Analysis Report
Overall Assessment
This company scores 51/100 in our Smart Analysis, earning a C- grade. Out of 9 metrics analyzed, 3 register as strengths (avg 10.0/10) while 6 fall into concern territory (avg 3.3/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Sales, Price/Book, Institutional Own.. Valuation metrics including Price/Sales (0.46), Price/Book (0.89) suggest the stock is attractively priced.
The Bear Case
The primary concerns are Profit Margin, Return on Equity, Revenue Growth. Some valuation metrics including PEG Ratio (1.66) suggest expensive pricing. Growth concerns include Revenue Growth at 2.40%, which may limit upside. Profitability pressure is visible in Return on Equity at 2.76%, Operating Margin at 15.10%, Profit Margin at -2.35%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Profit Margin improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 2.76% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 2.40% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a moderate-to-high risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Mixed fundamentals with both positives (Price/Sales, Price/Book) and negatives (Profit Margin, Return on Equity). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
SGRY Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
SGRY's Price-to-Sales ratio of 0.46x trades at a deep discount to its historical average of 1.69x (0th percentile). The current valuation is 93% below its historical high of 6.25x set in Nov 2015, and 0% above its historical low of 0.46x in Mar 2026. Over the past 12 months, the PS ratio has compressed from ~1.0x as trailing revenue scaled faster than the stock price.
Compare SGRY with Competitors
Top MEDICAL CARE FACILITIES stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for Surgery Partners Inc (SGRY) · HEALTHCARE › MEDICAL CARE FACILITIES
The Big Picture
Surgery Partners Inc is in a turnaround phase, with management focused on restoring profitability. Revenue reached 3.3B with 2% growth year-over-year. The company is currently unprofitable, posting a -2.4% profit margin.
Key Findings
Generating 91M in free cash flow and 103M in operating cash flow. Earnings are translating into actual cash generation.
ROE of 2.8% suggests the company isn't efficiently converting equity into profits.
The company is unprofitable with a -2.4% profit margin. The path to breakeven will be the key catalyst.
What to Watch Next
Volatility is elevated with a beta of 1.94, so expect amplified moves relative to the broader market.
Sector dynamics: monitor MEDICAL CARE FACILITIES industry trends, competitive moves, and regulatory changes that could impact Surgery Partners Inc.
Bottom Line
Surgery Partners Inc is in turnaround mode. The path to profitability remains the critical question. Speculative investors may see opportunity in the recovery story, but conservative investors should wait for consistent positive earnings before committing capital.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About Surgery Partners Inc(SGRY)
NASDAQ
HEALTHCARE
MEDICAL CARE FACILITIES
USA
Surgery Partners, Inc. owns and operates a network of surgical facilities and ancillary services in the United States. The company is headquartered in Brentwood, Tennessee.